Mareike Frick

1.4k total citations
15 papers, 211 citations indexed

About

Mareike Frick is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Mareike Frick has authored 15 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Mareike Frick's work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Mareike Frick is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Mareike Frick collaborates with scholars based in Germany, Austria and Switzerland. Mareike Frick's co-authors include Walter Keller, A. Krämer, Georg Lenz, Bernd Dörken, Frédérik Damm, Lars Bullinger, Michael Hummel, Philipp le Coutre, Michael Grau and Martin Janz and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mareike Frick

15 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mareike Frick Germany 9 89 68 59 51 51 15 211
Elisa Bergaggio Italy 4 83 0.9× 56 0.8× 74 1.3× 25 0.5× 29 0.6× 6 180
Francesca Maria Quaglia Italy 10 68 0.8× 72 1.1× 112 1.9× 132 2.6× 45 0.9× 19 231
Agata Majchrzak Poland 7 81 0.9× 55 0.8× 66 1.1× 64 1.3× 41 0.8× 22 186
Sonia Ali United States 5 90 1.0× 63 0.9× 33 0.6× 32 0.6× 31 0.6× 11 181
Valentina Fragliasso Italy 9 176 2.0× 74 1.1× 41 0.7× 28 0.5× 41 0.8× 25 295
Tatjana Pandzic Sweden 8 94 1.1× 48 0.7× 64 1.1× 65 1.3× 26 0.5× 14 203
Kerstin Dietze Germany 6 125 1.4× 137 2.0× 147 2.5× 96 1.9× 112 2.2× 8 319
Stefan Koehrer United States 9 125 1.4× 83 1.2× 69 1.2× 110 2.2× 69 1.4× 14 287
Elisa Genuardi Italy 9 114 1.3× 110 1.6× 87 1.5× 51 1.0× 27 0.5× 25 231
Reinhild Brinker Germany 8 98 1.1× 53 0.8× 33 0.6× 80 1.6× 104 2.0× 10 239

Countries citing papers authored by Mareike Frick

Since Specialization
Citations

This map shows the geographic impact of Mareike Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mareike Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mareike Frick more than expected).

Fields of papers citing papers by Mareike Frick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mareike Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mareike Frick. The network helps show where Mareike Frick may publish in the future.

Co-authorship network of co-authors of Mareike Frick

This figure shows the co-authorship network connecting the top 25 collaborators of Mareike Frick. A scholar is included among the top collaborators of Mareike Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mareike Frick. Mareike Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Walter, Annette O., Benedikt Obermayer, David R. Busch, et al.. (2025). Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma. Journal for ImmunoTherapy of Cancer. 13(4). e010709–e010709. 6 indexed citations
2.
Frick, Mareike, et al.. (2025). Long-term surveillance recommendations for young adult cancer survivors. Cancer Treatment Reviews. 139. 102992–102992. 1 indexed citations
3.
Damm, Frédérik, et al.. (2023). Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia. Cancers. 15(18). 4573–4573. 10 indexed citations
4.
Vetter, Valentin Max, Christopher Maximilian Arends, Lars Bullinger, et al.. (2022). Clonal hematopoiesis of indeterminate potential-related epigenetic age acceleration correlates with clonal hematopoiesis of indeterminate potential clone size in patients with high morbidity. Haematologica. 107(7). 1703–1708. 11 indexed citations
5.
Arends, Christopher Maximilian, et al.. (2022). Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New Agents. Cancers. 14(7). 1689–1689. 9 indexed citations
6.
Christen, Friederike, Raphael Hablesreiter, Kaja Hoyer, et al.. (2021). Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9. Leukemia. 36(4). 1102–1110. 12 indexed citations
7.
8.
Denker, Sophy, Il‐Kang Na, Julia Kase, et al.. (2019). A Phase I/II First-Line Study of R-Chop Plus B-Cell Receptor/NF-κB-Double-Targeting to Molecularly Assess Therapy Response. SHILAP Revista de lepidopterología. 8(4). IJH20–IJH20. 7 indexed citations
9.
Arends, Christopher Maximilian, Anthony Rousselle, Ralph Kettritz, et al.. (2019). 047. CLONAL HEMATOPOIESIS IN PATIENTS WITH ANCA-ASSCOCIATED VASCULITIS. Lara D. Veeken. 58(Supplement_2). 1 indexed citations
10.
Frick, Mareike, Marcus Bettstetter, Simone Bertz, et al.. (2017). Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL. Leukemia & lymphoma. 59(5). 1260–1263. 15 indexed citations
11.
Nogai, Hendrik, Stephan Hailfinger, Michael Grau, et al.. (2013). IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. Blood. 122(13). 2242–2250. 59 indexed citations
12.
Nogai, Hendrik, Stephan Hailfinger, Michael Grau, et al.. (2013). I{kappa}B-{zeta} controls the constitutive NF-{kappa}B target gene network and survival of ABC DLBCL. 4 indexed citations
13.
Frick, Mareike, et al.. (2011). Omacetaxine mepesuccinate for the treatment of leukemia. Expert Opinion on Pharmacotherapy. 12(15). 2381–2392. 15 indexed citations
14.
Frick, Mareike, Bernd Dörken, & Georg Lenz. (2011). The molecular biology of diffuse large B-cell lymphoma. Therapeutic Advances in Hematology. 2(6). 369–379. 14 indexed citations
15.
Krämer, A., Mareike Frick, & Walter Keller. (1987). Separation of multiple components of HeLa cell nuclear extracts required for pre-messenger RNA splicing.. Journal of Biological Chemistry. 262(36). 17630–17640. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisa Bergaggio Breakdown of academic impact, for papers by Francesca Maria Quaglia Breakdown of academic impact, for papers by Agata Majchrzak Breakdown of academic impact, for papers by Sonia Ali Breakdown of academic impact, for papers by Valentina Fragliasso Breakdown of academic impact, for papers by Tatjana Pandzic Breakdown of academic impact, for papers by Kerstin Dietze Breakdown of academic impact, for papers by Stefan Koehrer Breakdown of academic impact, for papers by Elisa Genuardi Breakdown of academic impact, for papers by Reinhild Brinker
Rankless by CCL
2026